Feedback / Questions
igrelimogene litadenorepvec (TILT-123) - Tilt Biotherap
https://www.globenewswire.com/news-release/2025/05/13/3079780/0/en/TILT-Biotherapeutics-Announces-Closing-of-USD-25-Million-Series-B-Financing.html
May 13, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next